Medical Devices Series B Investors & VC Firms
660 firms in this list, with a median first check of $730K. 140 of them lead rounds. Generated from verified public data and updated continuously.
PacBridge Capital Partners
Hong KongSeed–Growth
5 people
Pivotal Life Sciences
Seed–Late Stage
5 people
Saisei Ventures
CambridgePre-Seed–Growth
5 people
WONIK Investment Partners
SeoulSeries A–Late Stage
11 people
Extens
ParisSeries A–Series B$3.2M – $16.2M
2 people
Health Technology Holding (HTH)
Pre-Seed–Series B$500K – $1M
2 people
Montis Capital
WarsawSeries A–Growth$1.6M – $5.5M
2 people
New Business Venture Fund
ReykjavíkSeed–Series B$216K – $4.3M
2 people
The Finnish Innovation Fund Sitra
HelsinkiSeed–Late Stage$108K
2 people
VTC Ventures
RoanokePre-Seed–Series B$100K – $5M
6 people
ODYSSEE VENTURE
ParisSeed–Late Stage$1.1M – $11M
1 person
Redhills Ventures LLC
Las VegasSeed–Late Stage$125K – $7M
3 people
ACORN BIOVENTURES
New YorkSeed–Late Stage
4 people
Cape Fear BioCapital
DurhamPre-Seed–Series B
3 people
Bluebird Ventures
Palo AltoSeed–Series B
1 person
Air Liquide Venture Capital (ALIAD)
ParisSeed–Growth
WRF Capital
SeattlePre-Seed–Series B$100K – $2M
Redesign Health
New YorkSeed–Late Stage
2 people
HealthCare Ventures, LLC
CambridgeSeries A–Late Stage$1M – $20M
1 person
Majuven
SingaporeSeed–Late Stage
4 people
South China Venture Capital
ShenzhenSeed–Late Stage
4 people
Reverent Partners
SeoulSeries A–Late Stage
Épimède
LiègeSeed–Series B$1.1M – $7.6M
1 person
Fluke Venture Partners
KirklandSeed–Late Stage$1M – $4M
1 person
Related lists
Series B Investors & VC Firms (4094)Series B Investors & VC Firms in United States (1625)Medical Devices Investors & VC Firms (1393)SaaS Series B Investors & VC Firms (1317)Series B Investors & VC Firms in Global (1265)Enterprise Software Series B Investors & VC Firms (1242)Healthtech Series B Investors & VC Firms (1216)Medical Devices Seed Investors & VC Firms (1155)Medical Devices Series A Investors & VC Firms (1145)Fintech Series B Investors & VC Firms (1141)
Data sourced from public filings and firms' own websites — see our methodology.







